Sculptor Capital’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-546,683
Closed -$5.49M 695
2022
Q4
$5.49M Hold
546,683
0.1% 242
2022
Q3
$5.37M Hold
546,683
0.07% 347
2022
Q2
$5.35M Buy
546,683
+7,097
+1% +$69.4K 0.06% 396
2022
Q1
$5.27M Buy
539,586
+12,086
+2% +$117K 0.04% 419
2021
Q4
$5.14M Hold
527,500
0.04% 355
2021
Q3
$5.12M Hold
527,500
0.04% 322
2021
Q2
$5.14M Buy
+527,500
New +$5.16M 0.04% 318

Other funds holding AONC

Sculptor Capital's AONC Position: Q1 2023 in Review

Sculptor Capital sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 546,683 shares — an estimated $5.49M sold.

Sculptor Capital first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $5.49M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Sculptor Capital reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Sculptor Capital sold 546,683 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $5.49M.
  • Sculptor Capital first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • Sculptor Capital's American Oncology Network, Inc. Class A Common Stock position peaked at $5.49M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.